Journal
REGENERATIVE MEDICINE
Volume 13, Issue 3, Pages 295-307Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/rme-2017-0152
Keywords
cartilage; cell therapy; clinical trials; function; intra-articular; mesenchymal stem cells; MRI; MSC; osteoarthritis; pain
Categories
Funding
- Cellular Biomedicine Group Ltd.
Ask authors/readers for more resources
Aim: This study aimed to evaluate the safety and therapeutic potential of autologous human adipose-derived mesenchymal stem cells (haMSCs) in patients with osteoarthritis. Materials & methods: Safety and efficacy of haMSCs were preclinically assessed in vitro and in BALB/c-nu nude mice. 18 patients were enrolled and divided into three dose groups: the low-dose, mid-dose and high-dose group (1x10(7), 2x10(7) and 5x10(7) cells, respectively), provided three injections and followed up for 96 weeks. Results & Conclusion: The preclinical study established the safety and efficacy of haMSCs. Intra-articular injections of haMSCs were safe and improved pain, function and cartilage volume of the knee joint, rendering them a promising novel treatment for knee osteoarthritis. The dosage of 5x10(7) haMSCs exhibited the highest improvement (ClinicalTrials.gov Identifier: NCT01809769).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available